Assessing the Public Health Impacts of Legalizing Recreational
... Regular use that begins in adolescence and continues throughout young adulthood appears to produce cognitive impairment but it is unclear how reversible it is. Regular adolescent cannabis users are more likely to use other illicit drugs for reasons that remain a subject of debate. All of these ...
... Regular use that begins in adolescence and continues throughout young adulthood appears to produce cognitive impairment but it is unclear how reversible it is. Regular adolescent cannabis users are more likely to use other illicit drugs for reasons that remain a subject of debate. All of these ...
Name ______________________________ CH 204, Fall 2014 Assignment 9 – Cannabinoids
... a. CB1 and CB2 signaling may promote cardiovascular disease progression b. CB1 and CB2 signaling may activate cardioprotective mechanisms c. CB1 signaling may promote cardiovascular disease progression while CB2 signaling may active cardioprotective mechanisms. d. CB2 signaling may promote cardiovas ...
... a. CB1 and CB2 signaling may promote cardiovascular disease progression b. CB1 and CB2 signaling may activate cardioprotective mechanisms c. CB1 signaling may promote cardiovascular disease progression while CB2 signaling may active cardioprotective mechanisms. d. CB2 signaling may promote cardiovas ...
Marijuana: From People to Pets
... previous 5 years) and marijuana toxicosis cases in animals (which had increased 4-fold), although the study reported only 2 deaths from the “ingestion of baked goods made with medical grade tetrahydrocannabinol butter.” ...
... previous 5 years) and marijuana toxicosis cases in animals (which had increased 4-fold), although the study reported only 2 deaths from the “ingestion of baked goods made with medical grade tetrahydrocannabinol butter.” ...
CANNABIS-INDUCED IMPAIRMENT OF LEARNING AND MEMORY
... significant increase in the time taken to locate the platform and enhanced the memory impairment produced by scopolamine. This effect of cannabis decreased by memory enhancing drugs with piracetam resulting in the most-shorter latency compared with the cannabis. Biochemically, cannabis altered the o ...
... significant increase in the time taken to locate the platform and enhanced the memory impairment produced by scopolamine. This effect of cannabis decreased by memory enhancing drugs with piracetam resulting in the most-shorter latency compared with the cannabis. Biochemically, cannabis altered the o ...
A Scientific Perspective on Marijuana on the Eve of Its
... Delta-9-tetrahydrocannabinol (∆9-THC) a major compound found in all marijuana plants is the primary activator of CB1 receptors. CB2 receptors are mainly outside of the brain and may be responsible for most of the medically beneficial effects reported with medical marijuana treatment. The CB2 recepto ...
... Delta-9-tetrahydrocannabinol (∆9-THC) a major compound found in all marijuana plants is the primary activator of CB1 receptors. CB2 receptors are mainly outside of the brain and may be responsible for most of the medically beneficial effects reported with medical marijuana treatment. The CB2 recepto ...
Cannabis-induced psychosis and subsequent schizophrenia
... al, 2004). It is well established that psychotic symptoms may follow cannabis intake, and a number of reviews have concluded that such symptoms are generally short-lived and that total remission can be expected (Tunving, 1985; Thomas, 1993; Johns, 2001; Hall & Degenhardt, 2004). However, the transie ...
... al, 2004). It is well established that psychotic symptoms may follow cannabis intake, and a number of reviews have concluded that such symptoms are generally short-lived and that total remission can be expected (Tunving, 1985; Thomas, 1993; Johns, 2001; Hall & Degenhardt, 2004). However, the transie ...
UPDATE OF CANNABIS BACKGROUND PAPER
... Source: Response by the Minister of Police to Question for Written Reply no. 012012 for reply on 7 September 2001. Comparable data not available before 1994/95. “Miscellaneous” includes the same types of offences as “other” in Figure 2.2. This is a measure of apprehension events and enforcement effo ...
... Source: Response by the Minister of Police to Question for Written Reply no. 012012 for reply on 7 September 2001. Comparable data not available before 1994/95. “Miscellaneous” includes the same types of offences as “other” in Figure 2.2. This is a measure of apprehension events and enforcement effo ...
Medsafe application form to be prescribed the cannabis
... The physician requirements for application and approval to administer Sativex® provides a framework for the effective, safe and responsive use of this standardised cannabis pharmaceutical as an adjunctive or alternative treatment in specific chronic disease states or terminal illness. Sativex® is an ...
... The physician requirements for application and approval to administer Sativex® provides a framework for the effective, safe and responsive use of this standardised cannabis pharmaceutical as an adjunctive or alternative treatment in specific chronic disease states or terminal illness. Sativex® is an ...
Use of Cannabis Medicines in Clinical Practice
... in excessive quantities. This side effect can be largely avoided if oral dosing is approached carefully, as discussed in Part II. Patients should be advised that if they experience nervousness or other negative emotion they should remember that this effect is not unexpected and that it will pass aft ...
... in excessive quantities. This side effect can be largely avoided if oral dosing is approached carefully, as discussed in Part II. Patients should be advised that if they experience nervousness or other negative emotion they should remember that this effect is not unexpected and that it will pass aft ...
The Role of the Physician in “Medical” Marijuana
... All cannabis‐based and cannabinoid medications should be subjected to the rigorous scrutiny of the Federal Food and Drug Administration (FDA) 1 regulatory process. This process provides important protections for patients, making medications available only when they: 1) are standardized by identi ...
... All cannabis‐based and cannabinoid medications should be subjected to the rigorous scrutiny of the Federal Food and Drug Administration (FDA) 1 regulatory process. This process provides important protections for patients, making medications available only when they: 1) are standardized by identi ...
Effects of Mandrax and Cannabis on the cellular Abstract
... sleeping pill (van Zyl, 2001), as a result of it having sedative and hypnotic properties as well as some anticonvulsant and antitussive actions (Bennett et al., 1983). Mandrax taken orally is absorbed rapidly in the gastrointestinal tract. For oral use, it is supplied in amounts of 75–300 mg as the ...
... sleeping pill (van Zyl, 2001), as a result of it having sedative and hypnotic properties as well as some anticonvulsant and antitussive actions (Bennett et al., 1983). Mandrax taken orally is absorbed rapidly in the gastrointestinal tract. For oral use, it is supplied in amounts of 75–300 mg as the ...
Marijuana: What you need to know
... group of people over time showed a relationship between marijuana use and later development of psychosis. Marijuana use also worsens the course of illness in patients with schizophrenia and can produce a brief ...
... group of people over time showed a relationship between marijuana use and later development of psychosis. Marijuana use also worsens the course of illness in patients with schizophrenia and can produce a brief ...
Summary of Public Comment on Adding Intractable Pain as a Qualifying Condition for the MN Medical Cannabis Program
... Numerous studies have established, and anecdotal evidence supports, that medical cannabis is a safe and effective treatment for pain. In 1999, the National Academy of Sciences’ Institute of Medicine reported that pain can be mitigated by the therapeutic use of marijuana. Since 2007, three individual ...
... Numerous studies have established, and anecdotal evidence supports, that medical cannabis is a safe and effective treatment for pain. In 1999, the National Academy of Sciences’ Institute of Medicine reported that pain can be mitigated by the therapeutic use of marijuana. Since 2007, three individual ...
An Example Case Study
... chronic pain management. However, they are associated with adverse effects, especially during the commencement or change in dosing and administration. When opioids are used for prolonged periods drug tolerance, chemical dependency and addiction may occur. The other major group of analgesics are nons ...
... chronic pain management. However, they are associated with adverse effects, especially during the commencement or change in dosing and administration. When opioids are used for prolonged periods drug tolerance, chemical dependency and addiction may occur. The other major group of analgesics are nons ...
a to z guide of illicit and licit drugs
... products containing caffeine and also alternative food and drinks that could be consumed instead of those that contain caffeine. It is important to engage parents in caffeine education as many adults are not aware of the effects of caffeine and the amount of caffeine found in energy drinks. ...
... products containing caffeine and also alternative food and drinks that could be consumed instead of those that contain caffeine. It is important to engage parents in caffeine education as many adults are not aware of the effects of caffeine and the amount of caffeine found in energy drinks. ...
Drug Abuse Education Course
... • It effects the parts of the brain involved in attention, learning, memory, motivation and emotions. • Users have more suicidal thoughts and are more likely to report symptoms of depression than those who never used. • Marijuana intoxication impairs driving and contributes to poor performance in sc ...
... • It effects the parts of the brain involved in attention, learning, memory, motivation and emotions. • Users have more suicidal thoughts and are more likely to report symptoms of depression than those who never used. • Marijuana intoxication impairs driving and contributes to poor performance in sc ...
Marijuana Presentation 2014
... producing lower levels of tar than cigarettes (Grotenhermen, 2001) and fewer respiratory symptoms reported by users (Earleywine & Smucker Barnwell, 2007). However, these devices have also been shown to release ammonia which, when inhaled, can cause irritation and central nervous system effects, as w ...
... producing lower levels of tar than cigarettes (Grotenhermen, 2001) and fewer respiratory symptoms reported by users (Earleywine & Smucker Barnwell, 2007). However, these devices have also been shown to release ammonia which, when inhaled, can cause irritation and central nervous system effects, as w ...
the facts on marijuana
... Marijuana is a “Schedule I” drug according to the Drug Enforcement Administration (DEA), meaning it has a high abuse potential and no recognized medical indication. However, the Food and Drug Administration (FDA) has approved a particular ingredient within marijuana (THC) in a non-smoked form for ce ...
... Marijuana is a “Schedule I” drug according to the Drug Enforcement Administration (DEA), meaning it has a high abuse potential and no recognized medical indication. However, the Food and Drug Administration (FDA) has approved a particular ingredient within marijuana (THC) in a non-smoked form for ce ...
Marijuana: Impact on the Developing Adolescent Brain
... E. Coca cocaine yes Marijuana THC potential Erythroxylaceae coca ...
... E. Coca cocaine yes Marijuana THC potential Erythroxylaceae coca ...
Marijuana and the Impact on Addiction and
... of onset has decreased, & more individuals are seeking treatment for abuse/dependence While the causal link for the “Gateway Hypothesis” has not been proven, the association between marijuana use & later use of other drugs has been well established Use during pregnancy associated with later impaired ...
... of onset has decreased, & more individuals are seeking treatment for abuse/dependence While the causal link for the “Gateway Hypothesis” has not been proven, the association between marijuana use & later use of other drugs has been well established Use during pregnancy associated with later impaired ...
cannabinoids: cesamet®, marinol®, and sativex
... meet their criteria. Cesamet® is listed under antiemetic and antinauseant medications. ODB lists Marinol® only for its approved indications (not for pain). ...
... meet their criteria. Cesamet® is listed under antiemetic and antinauseant medications. ODB lists Marinol® only for its approved indications (not for pain). ...
Palliative Care in Winnipeg
... prescribe this substance, must be fully knowledgeable of the risks, benefits, potential complications, and drug ...
... prescribe this substance, must be fully knowledgeable of the risks, benefits, potential complications, and drug ...
MedicineDrugs-MindAlteringDrugs7PPT
... witchcraft, and enacted the first set of anti-drug laws in the Western Hemisphere, all aimed at wiping out Indian use of the plant. During the American Civil War, peyote use began spreading north from Mexico on a large ...
... witchcraft, and enacted the first set of anti-drug laws in the Western Hemisphere, all aimed at wiping out Indian use of the plant. During the American Civil War, peyote use began spreading north from Mexico on a large ...
Marijuana Usage In Chronic Pain Patients: Driving and Work
... patients, the media, scientific studies, or anecdotal reports. Regardless, there is a large body of data demonstrating that marijuana may cause significant mental status changes. These include altered perception, hallucinations, delusions, euphoria, and dysphoria.4 The individual smoking marijuana a ...
... patients, the media, scientific studies, or anecdotal reports. Regardless, there is a large body of data demonstrating that marijuana may cause significant mental status changes. These include altered perception, hallucinations, delusions, euphoria, and dysphoria.4 The individual smoking marijuana a ...
Medical cannabis
Medical cannabis, or medical marijuana, refers to the use of cannabis and its cannabinoids to treat disease or improve symptoms. The use of cannabis as a medicine has not been rigorously scientifically tested often due to restrictions on the production of the drug. There is limited evidence suggesting cannabis can be used to reduce nausea and vomiting during chemotherapy, to improve appetite in people with HIV/AIDS, and to treat chronic pain and muscle spasms. Its use for other medical applications is insufficient for conclusions about safety or efficacy.Short-term use increases both minor and major adverse effects. Common side effects include dizziness, feeling tired, vomiting, and hallucinations. Long-term effects of cannabis are not clear. Concerns include memory and cognition problems, risk of addiction, schizophrenia in young people, and the risk of children taking it by accident.The Cannabis plant has a history of medicinal use dating back thousands of years across many cultures. Its current use is controversial. The American Medical Association, the Minnesota Medical Association, the American Society of Addiction Medicine, and other medical organizations have issued statements opposing its use for medicinal purposes. The American Academy of Pediatrics states that while cannabinoids may have potential as therapy for a number of medical conditions, they do not recommend it until more research is done. They, along with the American Medical Association and the Minnesota Medical Association, call for moving cannabis out of DEA Schedule I to facilitate this research.Medical cannabis can be administered using a variety of methods, including vaporizing or smoking dried buds, eating extracts, taking capsules or using oral sprays. Synthetic cannabinoids are available as prescription drugs in some countries; examples include: dronabinol and nabilone. Recreational use of cannabis is illegal in most parts of the world, but the medical use of cannabis is legal in certain countries, including Austria, Canada, Czech Republic, Finland, Germany, Israel, Italy, the Netherlands, Portugal and Spain. In the United States, federal law outlaws all cannabis use, while 20 states and the District of Columbia no longer prosecute individuals for the possession or sale of marijuana, as long as the individuals are in compliance with the state's marijuana sale regulations. However, an appeals court ruled in January 2014 that a 2007 Ninth Circuit ruling remains binding in relation to the ongoing illegality, in federal legislative terms, of Californian cannabis dispensaries, reaffirming the impact of the federal Controlled Substances Act.